Speakers

Katerina Akassoglou, University of California, USA
The immunology of blood: Unlocking drivers of neurodegeneration

Katerina Akassoglou

Kari Alitalo, University of Helsinki, Finland
Targeting meningeal lymphatics in CNS disease

Kari Alitalo

Christer Betsholtz, Karolinska Institutet and Uppsala University, Sweden
Mapping the brain barriers by single-cell RNA sequencing

Christer Betsholtz

Matthew Campbell, Trinity College Dublin, Ireland
Dynamic regulation of claudin-5 at the blood-brain and blood-retina barrier

Matthew Campbell

Peter Carlsson, University of Gothenburg, Sweden
Foxf2 control of brain endothelial metabolism and consequences for neuronal health and survival

Peter Carlsson

William Elmquist, University of Minnesota, USA
Heterogeneity in Transport Mechanisms at the BBB: A critical determinant of efficacy in brain tumors

William Elmquist

Britta Engelhardt, University of Bern, Switzerland
The brain barriers maintain CNS immune privilege

Britta Engelhardt

Viviana Gradinaru, Caltech, USA
Engineered gene delivery vectors for high-precision minimally-invasive access to and across the brain vasculature across species

Viviana Gradinaru

Margareta Hammarlund-Udenaes, Uppsala University, Sweden
Targeting CNS disorders – is enough drug reaching the brain? On drug delivery across the blood-brain barrier.

Margareta Hammarlund-Udenaes

Annika Keller, University Hospital Zurich, Switzerland
Pericytes regulate vascular immune homeostasis in the CNS

Annika Keller

Maria Lehtinen, Boston Children’s Hospital, USA
New roles for the blood-CSF barrier in health and disease

Maria Lehtinen

Stefan Liebner, Goethe University Frankfurt, Germany
Regulation of endothelial permeability in circumventricular organs (CVOs) – sites of neurovascular coupling

Stefan Liebner

Maiken Nedergaard, Nedergaard Lab, USA and University of Copenhagen, Denmark
The Glymphatic System

Maiken Nedergaard

Prakash Ambady and Edward Neuwelt, Oregon Health & Science University, USA
Looking back at the past 50 years of intra-arterial delivery and blood-brain barrier disruption

Prakash Ambady and Edward Neuwelt

Timothy Phoenix, University of Cincinnati, USA
Drivers of vascular heterogeneity in brain tumors

Timothy Phoenix

Jann Sarkaria, Mayo Clinic, USA
Distribution of the novel DNA-PK inhibitor nedisertib into brain and brain tumor and the impact on radiation sensitivity

Jann Sarkaria

Stina Syvänen, Uppsala University, Sweden
Bispecific brain penetrating antibodies for PET imaging and therapy

Stina Syvänen

Rudolph Tanzi, Massachusetts General Hospital East, USA
The Role of Innate Immunity in Alzheimer’s Disease Pathogenesis

Rudolph Tanzi

Li-Huei Tsai, Massachusetts Institute of Technology, USA
Using human stem cells and postmortem brains to study vascular dysfunction in Alzheimer’s disease

Li-Huei Tsai

Benoit Vanhollebeke, Université Libre de Bruxelles, Belgium
Single-cell control mechanism of brain angiogenesis and blood-brain barrier formation in vertebrates

Benoit Vanhollebeke

Berislav V. Zlokovic, University of Southern California, USA
Blood-brain barrier Link to Neurodegeneration: Implications for cognitive impairment, dementia and Alzheimer’s disease

Berislav V. Zlokovic

Joy Zuchero, Denali Therapeutic Inc. USA
Using the Transport Vehicle to Deliver CNS Therapeutics Across the Blood-Brain Barrier

Joy Zuchero